Literature DB >> 3280613

System approaches in pharmacokinetics: I. Basic concepts.

P Veng-Pedersen1.   

Abstract

System approaches mathematically describe a general property of a pharmacokinetic system without modeling in specific terms the kinetic processes responsible for the general property considered. Definitions, basic concepts, kinetic basis, and rationale for system approaches as well as advantages and disadvantages of system approaches are presented and discussed. It appears that the system approaches may offer certain advantages over more traditional methods for many practical applications.

Mesh:

Year:  1988        PMID: 3280613     DOI: 10.1002/j.1552-4604.1988.tb03094.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  5 in total

Review 1.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

2.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

3.  Clearance of polychlorinated biphenyl atropisomers is enantioselective in female C57Bl/6 mice.

Authors:  Izabela Kania-Korwel; Mohammed H M E El-Komy; Peter Veng-Pedersen; Hans-Joachim Lehmler
Journal:  Environ Sci Technol       Date:  2010-04-15       Impact factor: 9.028

4.  Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.

Authors:  Peter Veng-Pedersen; Kevin J Freise; Robert L Schmidt; John A Widness
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

5.  Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers.

Authors:  Mohammed H Elkomy; Shahira F El Menshawe; Heba A Abou-Taleb; Marwa H Elkarmalawy
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.